BCL6B and breast carcinoma: Mechanistic insights suggest that BCL6B suppresses CD24 and CD47 expression, enhancing macrophage phagocytic activity by increasing antibody binding sensitivity, revealing a novel link between immune checkpoint modulation and BCL6B function in breast cancer.